FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
Category: #health  By Mateen Dalal  Date: 2020-08-28
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen

Abbott Laboratories, a U.S.-based medical devices and healthcare firm, has reportedly received the Emergency Use Authorization (EUA) from the U.S. FDA (Food and Drug Administration) for the detecting COVID-19 virus with its portable antigen test BinaxNOW™.

For the uninitiated, BinaxNOW™ is a portable, fast, and reliable test that uses Abbott’s lateral flow technology in order to detect antigens at a massive scale. The tool requires minimal equipment and provides test results in 15 minutes. The company plans on selling each test for $5.

As per the study conducted by Abbott along with leading research universities, the test results of the BinaxNOW COVID-19 Ag Card reflected 98.5% specificity (negative percent agreement) and 97.1% sensitivity (positive percent agreement) within the first seven days of individuals being suspected of contracting the COVID-19 virus.

The FDA marketing authorization comes after the antigen test kit was approved for use by healthcare professionals conducting point-of-care tests operating under Clinical Laboratory Improvement Amendments (CLIA) Certificates of Compliance, Certificate of Waiver as well as Certificate of Accreditation.

According to credible sources, Abbott will also launch NAVICA™, a mobile-based application compatible with Android and iOS devices. The BinaxNOW test will function on a reactive card paired with the application that is intended to work as a temporary digital health pass for individuals who test negative for Coronavirus.

Moreover, the interactive application will be free of cost and will encourage information such as social distancing and mask-wearing on the mobile devices.

CEO and President of Abbott Laboratories, Robert B. Ford, was reported saying that the two platforms launched by the company are collectively aimed at providing an affordable and convenient testing solution for the residents of U.S. in an effort to make them feel more confident about their lives and general health.

In other news, the U.S. FDA (Food and Drug Administration) has reportedly granted approval for healthcare agencies to use convalescent plasma for the treatment of the COVID-19 virus. The administration claimed that the benefits of the plasma outweigh the potential risks.

Source credits: https://www.prnewswire.com/news-releases/abbotts-fast-5-15-minute-easy-to-use-covid-19-antigen-test-receives-fda-emergency-use-authorization-mobile-app-displays-test-results-to-help-our-return-to-daily-life-ramping-production-to-50-million-tests-a-month-301119289.html

Other news: https://health.economictimes.indiatimes.com/news/pharma/us-fda-approves-blood-plasma-therapy-to-treat-covid-19/77719806

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Lufthansa Group to swap old A340 planes with 10 new long-haul jets

Lufthansa Group to swap old A340 planes with 10 new long-haul jets

By Mateen Dalal

The parent company of German airline Deutsche Lufthansa AG, Lufthansa Group, reportedly said it would purchase a total of 10 long-haul aircraft, including 5 Boeing B787-9s and 5 Airbus A350-900s, to replace aging Airbus A340 planes in an effort to mo...

Facebook, Google sign content deals with Australia’s Seven West Media

Facebook, Google sign content deals with Australia’s Seven West Media

By Mateen Dalal

Seven West Media, an Australian newspaper and television firm, has reportedly signed a content deal with Facebook Inc. and Google LLC in the wake of recent landmark laws that have enabled the industry to obtain new revenue sources and adapt to the in...

Microsoft considered reducing Xbox Store fee to revive console gaming

Microsoft considered reducing Xbox Store fee to revive console gaming

By Mateen Dalal

Multinational tech-giant Microsoft was reportedly looking to lower its Xbox store commission fee to a meager 12% from the previous 30%, as per confidential documents submitted in the Epic Games and Apple case. The document from January also contains...